Präsentation
Filtern
Dokumenttyp
- Vortrag (2)
- Posterpräsentation (1)
Sprache
- Englisch (3)
Referierte Publikation
- nein (3) (entfernen)
Schlagworte
- Antibody Quantification (1)
- Antibody quantification (1)
- Corundum (1)
- DNA-Sequencing (1)
- Enzyme Immobilisation (1)
- LC-MS/MS (1)
- Metrology (1)
- Monoclonal Antibodies (1)
- PCR (1)
- Traceability (1)
Organisationseinheit der BAM
Eingeladener Vortrag
- nein (2)
Therapeutic monoclonal antibodies are the fastest-growing group of biological agents which generated a yearly turnover of USD 210 billion in 2022 and whose sales are expected to grow by 10% annually over the next 10 years. With steadily increasing market importance, analytical methods for reliable quantification of therapeutic antibodies also become more and more relevant. Liquid chromatography coupled with tandem mass spectrometry (LC–MS/MS) has become the main technology for antibody quantification. This approach, however, requires enzymatic digestion of the intact protein into peptides, for which a wide range of different protocols exists that often lead to different results depending on the digestion procedure or trypsin variants used. In particular, the amount and type of detergents added for protein unfolding prior to digestion is known to create significant bias in measurement results. The overall goal of the presented project is the application of novel thermostable and surface-functionalized trypsin particles for improved antibody digestion. Specifically, a trypsin-variant described in the literature exhibiting increased activity and thermal stability above 80°C, will be examined. The application of this enzyme should allow to perform digestion at elevated temperatures where the protein is naturally unfolding thereby increasing enzyme accessibility without the need for detergents. Furthermore, we will immobilize the thermostable trypsin onto the surface to further enhance enzyme stability, prevent self-digestion, and enable separation of trypsin from target peptides before LC–MS/MS analysis. As an immobilization platform, cheap and non-porous corundum particles will be used as these show high chemical stability and low levels of interaction of matrix proteins with the functionalized surface. adsorption. In a multidisciplinary collaboration with the SALSA Photonics Lab, we will investigate the characteristics of covalent enzyme binding and unspecific peptide binding using an interface-sensitive analytical tool, vibrational sum-frequency generation (VSFG) spectroscopy. The insights gained will not only lead to new competencies in peptide and enzyme surface analysis using VSFG spectroscopy in SALSA but will also significantly contribute to optimizing antibody quantification.
With the development of hybridoma technology, monoclonal antibodies are increasingly important in therapeutic and analytical applications. For recombinant expression in mammalian cells, knowledge of the variable regions of both, heavy (VH) and light (VL) chain, is a necessary prerequisite for generating expression plasmids. Furthermore, cloning antibody sequences including constant regions CH1 to CH3 and CL reduces impact of hybridoma cell loss and associated full natural antibody sequence leakage. Here, we show a cost-effective workflow for amplification of IgG antibody variable regions in combination with advanced methods for full-length cloning of monoclonal antibodies.
The metrological analysis uses an unbroken chain of comparative measurements to trace results back to the national or international standard. This enables comparable, absolute quantification between laboratories. In 2020/2021, a pilot study for the quantification of SARS-CoV-2 antibodies was initiated with the involvement of BAM. Despite the consistent use of ID-MS, a large discrepancy in the results of the participating laboratories was found. This was the motivation for a project to systematically investigate and optimize traceable methods of protein quantification using mass spectrometric nontarget analysis (NTA) and recombinant antibody panels.